UBS Remains Sidelined on New Relic (NEWR) as Challenges Overshadow 2Q Upside
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
New Relic (NEWR) Tops Q2 EPS by 8c
November 7, 2016 4:21 PM ESTNew Relic (NYSE: NEWR) reported Q2 EPS of ($0.09), $0.08 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $63.4 million versus the consensus estimate of $61.93 million.
"New Relic is rapidly becoming the global enterprise standard for a new category of software we call Digital Intelligence. At the end of... More
Trading Radar for 11/7: MGM Resorts (MGM), LendingClub (LC), Dean Foods (DF), Ferrari (RACE), Sysco (SYY) Report
November 4, 2016 3:49 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
ARIAD Pharma (Nasdaq: ARIA) - consensus loss $0.19
Altisource Residential (Nasdaq: RESI) - consensus loss $0.48
Amicus Therapeutics (Nasdaq: FOLD) - consensus loss $0.34
ArQule (Nasdaq: ARQL) - consensus loss $0.09
Aralez Pharma (Nasdaq: ARLZ) - consensus loss $0.37
Ardelyx (Nasdaq: ARDX) -... More
